Dai L, Liu M, Ke W, Chen L, Fang X, Zhang Z
Cell Mol Life Sci. 2024; 81(1):382.
PMID: 39223418
PMC: 11368888.
DOI: 10.1007/s00018-024-05419-5.
Ichikawa Y, Sato B, Hirano S, Takefuji Y, Satoh F
Med Gas Res. 2024; 14(3):89-95.
PMID: 39073335
PMC: 466992.
DOI: 10.4103/2045-9912.385949.
de Oliveira M, Melo E, Silva T, Cardozo C, Siqueira I, Hamaji M
Molecules. 2023; 28(18).
PMID: 37764284
PMC: 10536462.
DOI: 10.3390/molecules28186508.
Eker F, Bolat E, Pekdemir B, Duman H, Karav S
Front Aging Neurosci. 2023; 15:1204149.
PMID: 37731953
PMC: 10508234.
DOI: 10.3389/fnagi.2023.1204149.
Cerasuolo M, Di Meo I, Auriemma M, Trojsi F, Maiorino M, Cirillo M
Int J Mol Sci. 2023; 24(11).
PMID: 37298586
PMC: 10253771.
DOI: 10.3390/ijms24119637.
The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer's Disease, Amyotrophic Lateral Sclerosis and Aging.
Kupershmidt L, Youdim M
Cells. 2023; 12(5).
PMID: 36899898
PMC: 10001413.
DOI: 10.3390/cells12050763.
Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration.
Ryan S, Zelic M, Han Y, Teeple E, Chen L, Sadeghi M
Nat Neurosci. 2022; 26(1):12-26.
PMID: 36536241
PMC: 9829540.
DOI: 10.1038/s41593-022-01221-3.
Metabolic profile-based subgroups can identify differences in brain volumes and brain iron deposition.
Lumsden A, Mulugeta A, Makinen V, Hypponen E
Diabetes Obes Metab. 2022; 25(1):121-131.
PMID: 36053807
PMC: 10946804.
DOI: 10.1111/dom.14853.
Tip60/Kat5 may be a novel candidate histone acetyltransferase for the regulation of liver iron localization via acetylation.
Baltaci N, Toraman E, Akyuz M, Kalin S, Budak H
Biometals. 2022; 35(6):1187-1197.
PMID: 35986817
DOI: 10.1007/s10534-022-00435-z.
Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology.
Wang Y, Tang B, Zhu J, Yu J, Hui J, Xia S
Int J Biol Sci. 2022; 18(10):4260-4274.
PMID: 35844784
PMC: 9274504.
DOI: 10.7150/ijbs.72251.
C19orf12 ablation causes ferroptosis in mitochondrial membrane protein-associated with neurodegeneration.
Shao C, Zhu J, Ma X, Siedlak S, Cohen M, Lerner A
Free Radic Biol Med. 2022; 182:23-33.
PMID: 35182730
PMC: 8957567.
DOI: 10.1016/j.freeradbiomed.2022.02.006.
In vivo brain iron concentration in healthy individuals at 3.0 T magnetic resonance imaging: a prospective cross-sectional study.
Holz T, Kunzler F, Forte G, Difini J, Soder R, Watte G
Br J Radiol. 2022; 95(1133):20210809.
PMID: 35119909
PMC: 10993970.
DOI: 10.1259/bjr.20210809.
Alteration of Iron Concentration in Alzheimer's Disease as a Possible Diagnostic Biomarker Unveiling Ferroptosis.
Ficiara E, Munir Z, Boschi S, Caligiuri M, Guiot C
Int J Mol Sci. 2021; 22(9).
PMID: 33923052
PMC: 8123284.
DOI: 10.3390/ijms22094479.
Iron Metabolism Disorders for Cognitive Dysfunction After Mild Traumatic Brain Injury.
Huang S, Li S, Feng H, Chen Y
Front Neurosci. 2021; 15:587197.
PMID: 33796002
PMC: 8007909.
DOI: 10.3389/fnins.2021.587197.
Assessment of Urinary Lead (Pb) and Essential Trace Elements in Autism Spectrum Disorder: a Case-Control Study Among Preschool Children in Malaysia.
Abd Wahil M, Jaafar M, Md Isa Z
Biol Trace Elem Res. 2021; 200(1):97-121.
PMID: 33661472
PMC: 7930527.
DOI: 10.1007/s12011-021-02654-w.
Age-Related Changes and Sex-Related Differences in Brain Iron Metabolism.
Grubic Kezele T, Curko-Cofek B
Nutrients. 2020; 12(9).
PMID: 32867052
PMC: 7551829.
DOI: 10.3390/nu12092601.
Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.
Chatterjee P, Mohammadi M, Goozee K, Shah T, Sohrabi H, Dias C
J Alzheimers Dis. 2020; 76(1):291-301.
PMID: 32538848
PMC: 7369053.
DOI: 10.3233/JAD-200162.
Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer's disease: Evidence of ferroptosis.
Ashraf A, Jeandriens J, Parkes H, So P
Redox Biol. 2020; 32:101494.
PMID: 32199332
PMC: 7083890.
DOI: 10.1016/j.redox.2020.101494.
Upregulation of Peroxiredoxin 3 Protects 2-KO Cortical Neurons from Oxidative Stress: A Paradigm for Neuronal Cell Survival under Neurodegenerative Conditions.
Bettegazzi B, Pelizzoni I, Salerno Scarzella F, Restelli L, Zacchetti D, Maltecca F
Oxid Med Cell Longev. 2019; 2019:4721950.
PMID: 31781336
PMC: 6875171.
DOI: 10.1155/2019/4721950.
The Functional Versatility of Transferrin Receptor 2 and Its Therapeutic Value.
Roetto A, Mezzanotte M, Pellegrino R
Pharmaceuticals (Basel). 2018; 11(4).
PMID: 30360575
PMC: 6316356.
DOI: 10.3390/ph11040115.